LAMP1 and post-transplant lymphoproliferative disease: The authors also showed functional differences between NK cells derived from PTLD patients compared to healthy controls (decreased CD107a, IFNγ), with augmentation of NK function in PTLD patients when they were treated with anti-PD-1 in vitro.